Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
AssigneeArtecel, Inc.
InventorsWilliam O. Wilkison, Jeffrey Gimble
Life of this patent
Estimating the term…
Abstract
The invention is in the area of pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof. In particular, the invention includes isolated adipose tissue derived stromal cells that have been induced to express at least one phenotypic characteristic of a neuronal, astroglial, hematopoietic progenitor, or hepatic cell. The invention also includes an isolated adipocyte tissue-derived stromal cell that has been dedifferentiated such that there is an absence of adipocyte phenotypic markers.
Claims48
An isolated adipose tissue derived stromal cell has been induced to express at least one characteristic of a neuronal cell.
An isolated adipose tissue derived stromal cell has been induced to express at least one characteristic of an astroglial cell.
An isolated adipose tissue derived stromal cell has been induced to express at least one characteristic of a hematopoietic progenitor cell.
An isolated adipose tissue derived stromal cell that has been induced to express at least one characteristic of a hepatic cell.
An isolated adipose tissue derived stromal cell that has been dedifferentiated such that it has an absence of phenotypic adipose markers.
An isolated adipose tissue derived stromal cell has been induced to express at least one characteristic of a neurona, astroglial, or hematopoietic progenitor, or hepatic cell in which at least one non-endogenous nucleic acid sequence has been introduced into the cell.
A method for treating a neurological disorder in a host comprising administering an isolated adipose tissue derived stromal cell that has been induced to express at least one characteristic of a neuronal cell.
A method for treating a neurological disorder in a host comprising administering an isolated adipose tissue derived stromal cell that has been induced to express at least one characteristic of an astroglial cell.
A method of improving hepatic function in a patient, comprising administering adipose tissue derived stromal cells induced to express at least one characteristic of a hepatic cell into the hepatic system of a patient.
A method of improving hematopoietic function in a patient, comprising administering adipose tissue derived stromal cells induced to express at least one characteristic of a hematopoietic progenitor cell into the hematopoietic system of a patient.
A method for dedifferentiating isolated adipose tissue-derived stromal cells comprising:
- plating said isolated adipose tissue-derived stromal cells and incubating said cells in medium comprising serum and an embryonic extract.
A method for dedifferentiating isolated adipose tissue-derived stromal cells, comprising:
- plating said isolated adipose tissue-derived stromal cells at a density of approximately 1,000 to 500,000 cells/cm2 and incubating said cells in medium comprising i) serum;
- ii) at least one compound selected from the group consisting of:
- growth factors, hormones, cytokines and serum factors;
- and iii) optionally, an embryonic extract.
A method for inducing an isolated adipose tissue-derived stromal cell to differentiate into a cell of non-mesenchymal lineage, comprising:
- plating said isolated adipose tissue-derived stromal cells and incubating said cells in medium comprising i) serum;
- ii) at least one compound selected from the group consisting of:
- growth factors, hormones, cytokines and serum factors;
- and iii) an embryonic extract.
A pleuripotent stem cell generated from isolated adipose tissue-derived stromal cells.
A method for providing differentiated cells of a non-mesenchymal lineage to a subject, comprising:
- a) plating said isolated adipose tissue-derived stromal cells at a density of 1,000 to 500,000 cells/cm2 and incubating said cells in medium comprising serum and an embryonic extract;
- b) introducing the cells from step (a) into said subject;
- wherein cells of the desired type are typically present at corresponding site in a normal subject.
A dedifferentiated, isolated, adipose tissue derived stromal cell capable of being induced to express at least one characteristic of a non-adipose tissue derived cell.
An isolated adipose tissue derived stromal cell has been induced to express at least one characteristic of a neuronal cell.
A composition that includes an adipose tissue derived stromal cell has been induced to express at least one characteristic of an astroglial cell in combination with a pharmaceutically acceptable carrier.
A composition that includes an adipose tissue derived stromal cell has been induced to express at least one characteristic of a hematopoietic progenitor in combination with a pharmaceutically acceptable carrier.
A composition that includes an adipose tissue derived stromal cell has been induced to express at least one characteristic of a neuronal, astroglial, hematopoietic, or hepatic derived cell wherein at least one non-endogenous nucleic acid sequence has been introduced into the stromal cell, in combination with a pharmaceutically acceptable carrier.
An isolated adipose tissue derived stromal cell has been induced to express at least one characteristic of a neuronal cell in a two or three dimensional framework suitable for implantation into a host
An isolated adipose tissue derived stromal cell has been induced to express at least one characteristic of an astroglial cell in a two or three dimensional framework suitable for implantation into a host.
An isolated adipose tissue derived stromal cell has been induced to express at least one characteristic of a hematopoietic progenitor cell in a two or three dimensional framework suitable for implantation into a host.
An isolated adipose tissue derived stromal cell that has been induced to express at least one characteristic of a hepatic cell in a two or three dimensional framework suitable for implantation into a host.
Dependencies are inferred from the claim text.